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Abstract. Systemic hyperinsulinaemia induces vasodi­
latation in hum an skeletal muscle. This effect is gra­
dual in onset, and at low insulin levels not maximal 
until a t  least 3 h. To investigate whether the vasodi­
lator response to insulin results from a direct vascular 
effect, we infused insulin directly into the cannulated 
brachial artery (perfused forearm technique) in a total 
o f  30 experiments in 20 healthy, lean, normotensive 
volunteers. Local, intra-arterial, infusion of  insulin 
(180 min, O O m U d L “ 1 forearm volum em in” 1, « =  15, 
forearm venous insulin concentration approximately 
5 4 0 p m o lL -1) induced a gradual increase in forearm 
blood flow (FBF; venous occlusion plethysmography) 
from 1-86 ±  0*17 to 3*64 ±  0 ,6 4 m L d L " 1 m in~ l after 
180 min (a n o v a  P <  0-001), Percentage increases in 
F B F  after 60, 120 and 180 min averaged 14*4 ±  5-9, 
59*4 ±  25*5 and 124*6 ±  51*2% respectively. Fore­
arm glucose uptake increased from 0*24 ±  0-05 to a 
maximum of 1*98 ±  0-28 /.¿moldL~l min (P < 0 001). 
Furtherm ore, insulin infusion increased forearm lac­
tate release and  potassium uptake. In 10 out o f  these 
15 individuals, the forearm glucose uptake was further 
increased in a second, separate, repeat experiment 
with concom itant intra-arterial infusion of glucose 
5% (O ^m LdL™ 1 m in-1 ), resulting in forearm 
venous glucose concentrations o f  approximately 
15 m m ol L"*1. This combined infusion achieved a simi­
lar vasodilator response to the infusion of  insulin 
alone. The individual vascular responses of the two 
paired experiments showed a strong correlation 
(r =  0*87, P < 0*01). In five subjects time and vehicle 
control experiments were performed, showing no 
changes in F B F  or metabolism during the 180 min. 
W e conclude tha t  the slow vasodilator response to 
insulin (as observed during systemic infusion) can, at 
least partly, be explained by a direct vascular effect o f  
insulin. Insulin-mediated skeletal muscle glucose 
up take  precedes this effect, but seems not to be an 
im p o rtan t  determ inant o f  the vasodilator response to 
insulin.
C orrespondence :  C. J J .  Tack ,  Division o f  General Internal 
Medicine, D e p a r tm e n t  o f  Medicine, University Hospital Nijmegen, 
G e e r t  G roo tep le in  Z u id  8, P O  Box 9101, 6500 HB Nijmegen, The 
N e the r lands .
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Introduction
In acute experiments in humans, systemic insulin 
infusion with maintenance of euglycaemia, exerts a 
vasodilator effect in skeletal muscle [1 -3]. This insulin- 
induced vasodilatation has been found to be reduced in 
disorders characterized by insulin resistance such as 
obesity [1], hypertension [4] and non-insulin-dependent 
diabetes mellitus (NIDDM ) [5]. As insulin-mediated 
skeletal muscle vasodilatation significantly contributes 
to the disposal of glucose, a diminished vasodilator 
capacity in itself explains part of the decreased insulin 
sensitivity in insulin-resistant states [1,4,5]. Therefore, 
further research on the phenomenon o f  insulin-induced 
vasodilatation may be of clinical importance.
Controversy exists as to whether the vasodila tor 
response to physiological hyperinsulinaemia results 
from a direct effect of insulin on the vascu lar  wall. 
Whereas some authors have found an increase in 
blood flow in response to local insulin adm inis tra tion  
[6,7], others have not [8-10]. Based on the  latter 
findings it has been concluded that the insulin-induced 
vasodilatation is centrally mediated [11,12]. In  the 
present study we have carefully investigated the 
effect of regional hyperinsulinaemia on the putative 
vasodilatation in the skeletal muscle vascu la r  bed, 
with special attention to the time course. U ntil  now 
very little attention has been given to the tim e course 
of the insulin-induced vasodilator effect, w hich  may 
be an important clue with respect to the controversia l 
observations in the literature. F rom  d a ta  o f  Laakso 
et a l  [1], it is obvious that the vasodila tor effect of 
systemic insulin infusion (physiological p lasm a  insulin 
concentrations) is not maximal until 3 h o f  infusion, 
and that after 30 and 60 min, respectively, only 
approximately 10% and approximately 30 %  o f  the 
maximum effect has been reached. Recently, even 
slower increases in blood flow in response to  insulin 
have been reported [13,14]. On the o ther h an d ,  several 
studies in which insulin was administered locally have 
used only 20-30 min of  infusion time [9,10,15].
Finally, as insulin-mediated glucose up take  m a y  be 
an important determinant of the vasoactive effects o f
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insulin [14,16], this parameter was measured through­
out our studies and was artificially z*aised in a sub­
group by regional glucose infusion.
Methods
Subjects
The study group consisted of 20 healthy volunteers. 
All met the inclusion criteria: age between 18 and 35 
years, non-smoking, absence of hypertension (office 
blood pressure < 140/90 mmHg, measured after 5 min 
rest in the supine position), body mass index 
< 2 5 k g m -2 . Participants used no medication, with 
the exception of oral contraceptives. The participants 
were selected by advertisement and received a payment. 
All subjects had a negative family history of diabetes 
and hypertension. All participants gave written 
informed consent. The experimental protocol was 
approved by the hospital ethics committee.
Procedures
The experiments were performed with the subjects in 
supine position after an overnight fast, in a quiet, 
temperature-controlled room (23-24°C). Under local 
anaesthesia (0*3-0-4mL lidocaine HCl 2 0 m g m L "1), 
a 20-gauge catheter (Angiocath, Becton Dickinson, 
Sandy, UT, USA) was inserted into the left brachial 
artery and connected with an arterial pressure moni­
toring line (Viggo Spectramed, 5269-129) to a Hewlett 
Packard 78353B Monitor. Mean arterial pressure 
(MAP) was determined by the electronically integrated 
area under the brachial arterial pulse-wave curve. The 
arterial line was kept patent with saline infusion 
(3 m L h -1 with 2 U  heparin m L " 1 added). In the same 
arm a catheter (Venfion, 20G, 32mm) was inserted 
retrogradely into a deep forearm vein to obtain venous 
blood samples. On the contralateral side an identical 
catheter was inserted into a large forearm vein for 
blood sampling.
Forearm volume (FAV) was measured with the
water displacement method. Forearm blood flow
(FBF) was measured simultaneously in both arms,
with the arms elevated just above heart level, using
mercury-in-silastic strain-gauge venous occlusion
plethysmography as previously described [17]. FBF
was expressed in mL dL~1 FAV min“ 1, and in the text
1 1
abbreviated to m L dL  min . One minute before the 
start of the measurements, a wrist cuff was inflated to 
lOOmmHg above systolic blood pressure. The collect­
ing cuff around the upper arm was inflated to a 
pressure of 40mjmHg during eight heart cycles using 
a Hokanson E20 rapid cuff inflator. The strain gauges 
were connected with the Hokanson EC4 plethysmo- 
graphs. During a measurement period, 8-10 measure­
ments of FBF were performed, each lasting 
approximately eight heart cycles.
Net uptake or release of glucose, lactate and potas­
sium was calculated by simultaneous arterial and
venous blood sampling (see calculations). Venous 
blood was sampled while the wrist cuffs remained 
inflated. Samples for insulin, potassium, lactate and 
pyruvate were taken at hourly intervals.
Protocols
Insulin ( I )  experim en ts . in  15 individuals, after 
complete instrumentation, at least 30 min of rest 
were included to obtain a steady state, after which 
baseline measurements were performed and repeated 
after 15 min. When FBF was stable, insulin (Actrapid, 
Novo-Nordisk, Denmark) was infused into the bra­
chial artery, at a dose of  0-3 m U d L _I m in " 1 (volume 
50 ¡j,LdL m in“ 1) and continued for 180 min. Insulin 
50 U m L " 1 was twice diluted in lOOmL of 0*9% NaCl 
each time with the addition of 2 mL of human 
albumin 20% (Central Laboratory of  Blood transfu­
sion, Amsterdam). FBF was measured after 5,15 and 
thereafter every 15 min until 180 min.
Insulin ~h glucose ( I  -J- G) experim en ts . In 10 indi­
viduals, randomly selected out of the 15 who 
had participated in the first protocol, the entire 
experiment was repeated after at least 4 weeks, but 
now with the addition of 0*2m L d L '“1 m i n '1 glucose 
5% infusion.
C ontrol ( C ) experim ents. In five different indivi­
duals, time and vehicle control experiments were 
performed, following exactly the same protocol, but 
now saline with the addition of albumin 20% (as 
mentioned above) was infused into the brachial 
artery for 180 min.
A n a ly tica l m ethods. Plasma glucose was measured 
in duplicate using the glucose oxidation method 
(Beckman glucose analyzer 2, Beckman Instruments, 
Fullerton, CA, USA).
Plasma insulin was measured with an in-house 
double antibody radioimmunoassay (interassay coeffi­
cient of variation 6*2%). For quantification of  L-lactate 
(and pyruvate) in deproteinized blood (6% perchloric 
acid) an enzymatic assay (Lactate UV-kit; Boehringer 
Mannheim, Mannheim, Germany) with L-lactate 
dehydrogenase (L-LDH; EC 1.1.1.27) was performed. 
Because pyruvate concentrations remained at or below 
detection limit, these results were not used for further 
analyses. Potassium was measured with a standard 
procedure using a K +-ion selective electrode with a 
Hitachi 747 autoanalyser (Boehringer Mannheim).
C alculations and da ta  analysis. Forearm vascular 
resistance (FVR) was calculated by dividing MAP and 
FBF, and expressed in arbitrary units (AU). To 
correct for the increased fluid infusion in the second 
protocol, 0*2 was subtracted from the calculated 
FBF. F o r  every 30-min period the mean of the pre­
vious 30-min measurements was calculated and used 
in the subsequent analyses. Forearm  balances were
C) 1996 Blackweil Science Ltd, European Journal o f  Clinical hives ligation, 26, 772-778
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Tabic L  Characteristics of participants (mean ±  SD)
Number (M/F)
Age (years)
BMI (kg m -2)
Systolic BP {mmHg) 
Diastolic BP (mmHg) 
Fasting glucose (mmol L " 1) 
Arterial 
Venous
Insulin alone
15 (7:8) 
22Ö ± 4 -5  
20-7 ±  1-5 
120*5 ±  12-7 
76-9 ± 7 - 6
4-72 ±0-19  
4-47 ±0-23
Insulin +  glucose
10(4:6)
22-8 ±4-5  
20-9 ±  1-5 
117 9 iL 12-9 
74-5 ±  5-4
4-73 ±0-18 
4-2K ±  0-24
Control
5(2:3) 
23 i  1*2 
20*9 ± 0 -8  
119*5 ±  11*4
73*5 ±  7-6
4-66 ±0-21 
4-36 ± 0 -3 9
calculated as:
(Concentration^RTKRFAL concentration v e n o u s ) x FP F  
Forearm plasma flow (FPF) — FBF x (1 — hacmatocrit)
Effects of insulin on haemodynamic parameters 
were analysed using one-way repeated measures 
a n o v a ,  with insulin as dependent factor. Post hoc 
/-tests were performed to test differences o f  the various 
time points from baseline. The effect o f  insulin alone 
was compared with the effect of insulin +  glucose with 
the use of a two-way a n o v a  for paired observations, 
with insulin and insulin -I- glucose as dependent vari­
ables. All other (mainly metabolic) da ta  met require­
ments o f  normality and were statistically analysed with 
the use o f  Student's Kest, Correlations were calculated 
using Spearman’s rank correlation tests. For the rela­
tion between venous insulin concentrations and forearm 
glucose extraction [(GA -  G V)G A“ 1], linear regression 
was perfonned and the coefficients o f  regression were 
used for further analysis. All statistical analyses were 
performed using the SPSS personal computer software 
package.
Results in tables and figures are expressed as 
mean ±  SEM, unless otherwise indicated. Statistical 
significance was set at a value less than  0*05 (two- 
sided). NS means not significant.
i
Results
Base! in e ch ara c for is t i cs
Baseline characteristics of the three study groups are 
given in Table 1. Participants were lean, young, 
normotensive and had a strictly norm al fasting glu­
cose level.
Vascular responses to local hyperinsulinaemia
Insulin infusion led to deep venous forearm insu­
lin concentrations of 549 ±  43, 497 ±  53 and 
404 ±  50pmol L 1 after 60, 120 and 180 in respec­
tively, whereas arterial levels did not increase: 
57 ±  5, 57 ±  4, 54 ±  4 and 49 ±  4 p m o l L -1 (baseline,
60, 120 and 180 min respectively).
Local infusion of insulin induced a highly signi­
ficant increase in forearm blood flow over time,
from 1 *86 ±  0-17 to 3*64 ±  0*64mL d L ~ 1 min ( a n o v a  
P <  0*001). This vasodilatation did not occur before 
15 min, and was significantly different from baseline 
after 30 min. As can be seen in Fig. 1, the increase in 
FBF was gradual and even after 180 min, FBF did not 
seem to have reached a steady state. The increase in 
flow was attended by a significant decrease in F V R  
from 49*4 ±  3*6 to 33*1 ±4*2 AU ( a n o v a  P < 0*001). 
Also the control arm showed a slight increase in 
FBF over time (FBF from 1*57 ±0*16 to
l , ANOVA P — 0*061), but
the FBFcxpcrimental/FBP1 control arm iatÍO inCLeased SÍg
niñcantly (from 1*26 ±0*09 to 1*67 ±0*15, a n o v a  
P <  0*001), proving a true regional effect o f  insulin 
infusion [18],
min
Metabolic responses to local hyper insulinaemia
Arterial forearm glucose values did not change, 
whereas venous forearm glucose levels decreased to 
trough levels at 30 min and increased slightly a f te r­
wards (see Fig. 1). Calculated forearm glucose up take  
increased from 0*24 ±  0*05 to a m axim um  of 
1*98 ±  0*28 /¿moldL“ 1 min“ 1 (at 30 min, P <  0*001) 
and decreased slightly afterwards to 1*29 ±  0T9 
after 180 min (P < 0*01 vs. 30 min).
Insulin infusion increased forearm lactate release
(from baseline 70 ± 2 7  to 340 ±  52 nmol dL 1 m in  
after 120min, P<0*01) and uptake of  potassium  
(from -0-17 ±0-05 to 0-24 ± 0 -1 5 / i in o ld L " 1 m in -1 , 
P <  0*05, see also Table 2). No significant correlations 
were found between changes in mctabolic param eters  
and blood flow changes. Inherent to its metabolic 
effect, a positive relationship was observed between 
deep venous insulin concentrations and glucose 
extraction across the forearm vascular bed (P  <  0*01).
- i
Eff'e c ts of the a cldi l io n of g lu c ose
Infusion of glucose into the brachial artery led to 
venous glucose concentrations of approxim ately
IS m m o lL -1 (13*8 zb 1-0, 14*2 ±  1*0, 14*4 ±0*9 , 
15*9 ±  1*6, 15*2 ±  0*8 and 15*6 ±  1*8 mmol L~ \  after
30, 60, 90, 120, 150 and 180 min respectively). Sys­
temic venous glucose levels (measured at con tra la te ra l  
side) remained approximately 5 mmol L“ 1 (4-7 ±  0*1,
(C) 1996 Blackwell Science Ltd, European Journal o f  Clinical Investigation, 26, 7 7 2 - 7 7 8
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Figure 1. Time course o f  increase in forearm blood flow (AFBF) in 
both experimental and control arm (bottom), and o f  forearm 
arterial and venous glucosc concentrations (top) during 180min 
of intra-arterial insulin infusion.
4-8 ±0*1 and 4*9 ±  0T mmol L ~ \  after 60, 120 and 
180 min respectively). Venous insulin levels were com­
parable with those in the first set of experiments 
(568 ±  67, 637 ±  67 and 566 ±  89 pmol L~1, after 60, 
120 and 180 min respectively). The combination of 
hyperinsulinaemia and hyperglycaemia induced a sig­
nificant increase in flow (FBFcxperimenmi arm from
2-03 ±0-29 to 2-79 ±  0-28 m L d L -1 min-1 after
180min, a n o v a  P < O'Ol, see Fig, 2), whereas FBF 
in the control arm did not change (from 2T 3 ±  0-47 to 
2-34 ±  0-54mLdL~' min-1, P =  NS).
Comparing the paired data sets of insulin alone vs. 
insulin +  glucose infusion ( tf= 10),  no significant 
difference in the FBF changes between the two experi­
ments was observed (FBFexperimentai arm, insulin alone 
(I): from 1-63 ±0-12 to 1-78 ±0-12, 2*04 ±0*23, 
2*66 ±  0 '32m LdL~J min” 1; insulin +  glucose (I ±  G):
Time (min)
Figure 2. T ime course of increase in forearm blood flow (A FBF),  in 
the experimental arm  during 180min of insulin (I) or  insulin +  glu­
cose (I +  G) infusion into the brachial artery.
from 2-03 ±  0-29 to 2*30 ±  0*24, 2-53 ±  0*23, 
2-79 ±  0-28m L d L “ 1 min“ 1, values after 60, 120 and 
180 min respectively). Also the percentage increases in 
FBF of both paired experiments were not significantly 
different between the two experiments (increase after 30 
min: I, 7*7 ± 5 *2 %  vs. I +  G, 21-5 ±  8-1% P =  0*12; 
after 90 min: I, 24*9 ±  12*0% vs. I +  G, 24-9 ±  15*5% 
P =  1*00; after 150 min: I, 40*8 ±17*2%  vs. I +  G, 
40*3 ±  14*9% P =  0-97).
During I +  G , forearm lactate release (P  =  0*012) 
and potassium uptake (P =  0*086) reached higher 
levels than  during I alone (see Table 2), indicating a 
local increase of  metabolic pathways.
A significant correlation between the percentage 
increase in FB F during I alone and during concomi­
tant I 4- G  was established on various lime points. In 
Fig. 3 the correlation at 90 min is shown: r =  0-87, 
P =  0*001.
Vascular responses to sham procedure
In the control experiment, FBF did not change during
Table 2. Lactate release and potassium uptake at different time points (mean-rt SE)
r | - l  *Time
(min)
Lactate release (nm oL dL m in  ') Potassium uptake ( / /m o ldL "1 m in~ ‘)
I I +  G C I I +  G C
0 70 ± 2 7 102 ± 4 7 107 ± 7 1 -0*17 ±0*05 0 1 4  zh 0 *12 - 0 '0 5  ±  0-03
60 257 ±  65 793 ±  194 113 ± 6 8 0-10 ±0*10 0-28 ±  0-12 -0 -07  ±0*13
120 340 ±  52 798 ±  165 95 ± 5 0 0-32 ± 0 - 1 6 0-52 ±0*12 -0*00 ±  0*09
180* 0*24 ± 0 - 1 5 0-48 ±0*15 0-00 ±  0*07
I, local hyperinsulinaemia alone; I +  G, combination of local hyperinsulinaemia and  hyperglycaemia; C, sham experiment.
it) 1996 Blackwell Science Ltd, European Journal o f  Clinical Investigation, 26, 772-778
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Figure 3. Percentage change in forearm blood (low (FBF) after 90 
min of  cither insulin (I) alone or insulin +  glucose (I I- G) infusion 
into the brachial artery.
180 min intra-arterial infusion of saline +  albumin
(2-25 ±0-41, 2'10 ±  0-34, 1-85 ±  0-23, 2-00 J - 0-25, 
1 • 83 ±  0-22,1 -76 ±  0-18 and 1 -9 ±  0-21 mL d L " 1 m in " ', 
baseline, 30, 60, 90, 120,150 and 180 min respectively), 
Arterial and venous glucose concentrations as well as 
forearm glucose uptake remained at fasting levels (data 
not shown).
Discussion
The major new finding of the present study is that 
local insulin administration in the vascular bed of 
the hum an forearm skeletal muscle, leading to fore­
arm deep venous insulin levels in the physiological 
range, induces a moderate, but reproducible, degree of 
vasodilatation. This, however, is slow in onset and 
preceded by maximal forearm glucose-uptake. In 
fact, the time course of the vasodilatation is very 
similar to that found with systemic insulin administra­
tion, leading to similar insulin levels [13]. Furthermore 
artificial raising of glucose uptake by local hypergly- 
caemia did not influence the vasodilator response to 
insulin.
In recent years, various investigators, including 
ourselves, have shown the vasodilator capacities of 
insulin [1-3]. Interestingly, in various related disorders 
such as obesity, hypertension and NIDDM , character­
ized by insulin resistance [19,20], a decreased insulin- 
induced vasodilatation has also been reported [1,4,5]. 
The mechanism by which insulin exerts vasodilator 
effects could therefore be of great importance. 
Although not fully understood up to now, recent 
data seem to point towards a nitric oxide-dependent 
mechanism of action [7,21]. One of the controversies is 
whether the vasodilator response results from a direct 
effect on the vascular wall or from an indirect,
possibly central, mechanism [22]. In favour of the 
latter hypothesis is the fact that several investigators 
were not able to show any vasodilatation when 
insulin was infused locally [X 10,23).
Until now little attention has been given to the time 
course of insulin-induced vasodilatation or to the 
relation between the speed of onset of the vasodilator 
effect and the insulin (and glucose) concentration. 
From the data available, it is clear that during euglv* 
eaemie systemic hyperinsulinaemia, insulin-induced 
vasodilatation is slow in onset and takes at least 3h 
to obtain its maximal effect at physiological concen­
trations [1,13]. This is considerably longer than the 
time needed to reach maximal glucose uptake [1,16] 
and means that in studying blood fiow responses to 
insulin, not only concentration but also duration of 
infusion mav be critical (which will also hold true for
m
local infusion). In keeping with this, Lundgren et al. 
[24], reported an increase in calf blood How from 2'3 
to 3*2 after 2 h, but even further to 4*4 m l . dL 1 min 1 
after 6h  of  a iixed-dose insulin infusion.
Therefore it is obvious that in studying local vaso- 
dilator effects o f  insulin, sufficient time should be 
taken to allow' insulin to exhibit its full effects, as we 
did in this study. This fact could explain why some 
authors were not able to identify anv local action of
*  »
insulin, as a number of investigators infused insulin 
lor only 20 3 0 min [9JO, 15). Gelfand & Barrett (25| 
established a small increase in blood How alter SI) min, 
as did Neahring ct a i  [26|, and Jern [27), using a 
paired study approach (2-h local insulin infusion). It 
can be speculated that at higher insulin concentrations 
the vasodilator effect will appear earlier, and hence be 
found after 15 30 min [6,7].
In our study, the individual response to insulin, 
although reproducible, showed a high variability, 
ranging from no effect to more than doubling of 
the blood flow (Fig. 3). This high intormdividual 
variation has also been reported by others and 
related to the relative forearm muscle content [ 14]. 
Thus, studies with small sample sizes, have a con­
siderable risk of  a type 2 statistical error, which could 
have further contributed to the controversial (indiims 
up to now,
Whereas we show in this study that at least part of 
insulin's vasodilator action can be explained by a local 
effect on the vascular wall, our study was not intended 
to explain the exact mechanism of insulin's effect. It 
seems that insulin-mediated glucose uptake precedes 
vasodilatation in skeletal muscle, but this does not 
mean that these two actions are coupled. In our own 
study, the addition of extra glucose, which must 
certainly have accelerated glucose uptake [28], had 
no additional effect on the change in vascular resis­
tance. Only Edelman et al. have reported that blood 
How increased with higher glucose levels during a 
constant insulin concentration, [16]. Their results 
were, however, derived from complex, sequential 
(‘stepped') clamps, with a duration of approximately 
8h. Theoretically it may be possible that the changes
<(') 19% Blackwell Science Ltd, European Journal o f  Clinical Investigation, 26, 112 77S
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they observed were the consequence of  prolonged 
e x p o s u r e  to insulin alone (24|, and not o f  the higher 
glycaemie level. Others have found no dilVerences in 
How in relation to dilVerent glycaemie levels [28). 
Furthermore, Vollenweider ct <//. [29] have shown 
that insulin (with glucose) infusion induced vasodila­
tation, but fructose infusion alone, which increased 
carbohydrate oxidation comparably but had only 
minor effects on insulinaemia, did not stimulate skele­
tal muscle blood flow. As such it may be concluded that 
there is no lirm evidence that hyperglycaemia augments 
insulin-induced vasodilatation.
In our study glucose uptake increased rapidly, but 
then slightly decreased during the subsequent experi­
ment. During systemic hyperinsulinaemia, this
w ^  W t
decrease in glucose uptake over time is not observed. 
This finding is probably related to our experimental 
approach; owing to the increase in blood How and 
the lixed insulin infusion rate, forearm insulin con­
centrations decreased, leading to a decreased glucose 
extraction. In favour of this explanation is the fact 
that we found a significant, positive, intra-individual 
correlation between venous insulin concentrations 
and glucose uptake. Therefore this secondary decrease 
in forearm glucose uptake will be related to the 
experimental model, and hence although partly inevi­
table, unphysiologieal.
During regional hyperinsulinaemia, venous plasma 
glucose concentrations decreased to hypoglyeaemic 
levels. It is important to realize that this would also 
occur in euglycaemie clamps. The term euglycaemia 
refers to the arterial(ized) glucose concentration, but, 
owing it) the stimulatory elleet o f  insulin on glucose 
uptake, venous glucose concentrations will be con­
siderably lower. Further, it has to be stressed that, 
because of the local approach, no systemic hypogly- 
eaemia occurred in our studies.
We have fount!, as have others [30), that during 
local insulin infusion lactate release increases. How­
ever, there was no correlation established between 
lactate release and vasodilatation. Furthermore, 
daring the combination ol*hyperglycaemia and hyper- 
insulinaemia, lactate release further increased, sug­
gesting more active metabolic pathways, but the 
increase in blood How was not a Heeled. Also others 
have armied that it is unlikely that lactate increase 
accounts for insulin's vasodilator eiVeet [I],
In conclusion, we report that local hyperinsulinae- 
mia leading to physiological insulin levels in the 
human forearm induces a slow-onset local vasodilata­
tion that is preceded by maximal tissue glucose 
uptake. The time course o f  the ell eel seems to be 
similar to that found in studies in which insulin is 
infused systemicallv and indicates that the insulin-
*  1*
induced vasodilator eHect is mediated at least partly at 
the level o f  the skeletal muscle.
Although insulin-mediated skeletal muscle glucose 
uptake preceded the vasodilatory eHect, it seems not 
to be an im portant determinant o f  the vasodilator
Acknowledgment
This work was supported by grants of the Dutch 
Diabetes Research Foundation.
response.
References
1 Laakso M, I hIc I man SV, Brechtel CL Huron AD, Decreased 
oiled of insulin to stimulate skeletal blood How in obese man. A 
novel mechanism for insulin resistance. J Clin Invest 
1990;K5:IN44 5 1
2 Anderson HA, I lotl'mann R l \  Balon TW, Sinkey C*A, M ark AL. 
llyperinsulinemia produces both sympathetic neural activation 
and vasodilation in normal humans. J ( ! in  Invest I991;H7:2246
3 lack  (\JJ, Smits l \  Willemsen JJ, Lenders JWM, Thien T, 
Lutierman JA. M ee ts  of  insulin on vascular tone and  sym pa­
thetic nervous system in N1DDM. Diabetes 1996:45:15 22.
4 Huron AD, Brechlel-Hook CL Johnson AD. Hardin I). Skeletal 
muscle blood How. A possible link between insulin resistance 
anti blood pressure. Hypertension 1993:21:129 35.
5 Laakso M. Ldelmau SV, Brechtel Ci, Baron AD. Impaired 
insulin-mediated skeletal muscle blood How in patients with 
N ID D M . Diabetes 1992:41:1076 S3.
6 C'i eager MA, Liang t \  ( 'o ilman JD, Beta adrenergic-mediated 
vasodilator response to insulin in the human forearm. J Phar­
macol L \p  Ther 1985:235:709 14.
7 Steinberg UM, Brechtel CL Johnson A. l 'ineberg N, Baron AD, 
Insulin-mediated skeletal muscle vasodilation is nitric oxide 
dependent. A novel action o f  insulin to increase nitric oxide 
release..! ( 'tin Invest 1994:94:1172 9,
S Natali A, Bu//tgoli Ci, Taddei S et al. I’Heels o f  insulin on
t  n
hemodynamics and metabolism in human forearm. Diabetes 
|990;39;490 500.
9 Sakai K. Imai/umi T, Masaki IL Takeshita A. ItUra-arleriul 
infusion of insulin attenuates vasoreactivity in hum an forearm. 
Hypertension 1993:22:67 73.
10 Lembo <L Rcndina V, laecarino CL Lumen/a l ;. Volpe M. 
Trimarco H. Insulin reduces rellex forearm sympathetic vaso­
constriction in heullhy humans. Hypertension 1993:21:1015 19.
H Lem ho Ci, Napoli R, t 'apa ldo  H et al. Abnormal sympathetic 
overuelivitv evoked bv insulin in the skeletal muscle o f  patients* 4 -  I
with essential hypertension. J CMin Invest 1992:90:24 9.
12 Sauter A, Ciokfslein M. Lgel T, Ueta K. Mil eel o f  insulin on 
central catecholamines. Brain Res 1993:260:330 3.
13 Kandin I), Vollenweider l \  Tnppy L, Jequier L, Nicod P, 
Scherrer U. LlVeeis o f  adrenergic and cholinergic bloekadc on 
insulin-induced stimulation o f  call' blood How in humans. Am .1 
Physiol I994;247:R909 R916.
14 Uiriatnen T, Malmstrdm R, Miikimatiila S. Vki-Jarvinen 11. 
Methodological aspects, dose response characteristics and 
causes of  interindividua! variation in insulin stimulation of 
limb blood flow in normal subjects, Diabetologia 
1995:39:555 64.
15 Lembo (i ,  laecarino Ci, Remlina V. Volpe M. Trim arco  B. 
Insulin blunts sympathetic vasoconstriction through I he 
a2-adrenergic pathway in humans. Hypertension 1994: 
24:429 39.
(6 f {del man SV. Laakso M, Wallace P. Brecht el CL O  lei sky ,IM. 
Baron AD, Kinetics of  insulin-mediated and non-insulin- 
mediated glucose uptake in humans. Diabetes 1990;39;955 64.
17 Brakkee AJM , Vendrik AJH. Strain gauge plethysmography, 
theoretical and practical notes on a new designs. J Appl Phvsiol 
1966:21:701 4.
IK Benjamin N, C alver A, C‘oilier J, Robinson B, Valla nee I\ 
Webb D. Measuring forearm blood flow and interpreting the 
responses to drugs and mediators. Hypertension 1995:25:919 
23.
19 Reaven CiM. Banting lecture 1999: Role of  insulin resistance in 
human disease. Diabetes |999;37:1595 07.
20 D e b ro n /o  RA. berrannini L, Insulin resistance. A multifaceted 
syndrome responsible for N ID D M , obesity, hypertension.
< 19% Blackwell Science Ltd, European Journal o f  Cluneal Invesfiyatiotu 26, 772 77N
778 C. J. J.  TACK */<//.
dyslipidemia and atherosclerotic cardiovascular disease. Diabetes 
Care 1991;14:173-94.
21 Schcrrer U, Randiti D, Vollcnwcidcr P, Volleinveider L, Nicod 
P. Nitric oxide release accounts lor insulin's effects in humans. 
J Clin Invest 1995;94:2511-15.
22 Anderson EA, Mark AL. The vasodilator action o f  insulin. 
Implications for the insulin hypothesis of  hypertension. Hyper­
tension 1993:2 Î : 136-41.
23 Ferrannini E, Taddei S, Santoro D et al. Independent stimula­
tion o f  glucose metabolism and N *-K 1 exchange by insulin in 
the human forearm. Am J Physiol 1999;255:E953 E959.
24 Lundgren F, Edén E, Arfvidsson B, Lundholm K. Insulin time- 
dependent effects on the leg exchange of glucose and amino acids 
in man. Eur J Clin Invest 1991;21:421-9.
25 Gclfund RA, Barrett EJ. Effect of  physiologic hyperinsulinemia 
on skeletal muscle protein synthesis and breakdown in man, 
J Clin Invest 1997;90:1- 6.
26 Ncahring JM , Sicpniakowski K, ( irecue AS. l ;gau B. Insulin 
does not reduce forearm M-vasorcacti\ ity in obese h>pcitonsi\e 
or lean normotensive men. I lypcrtension F W 'O l . ^ O  4.
27 Jern S. Effects o f  insulin on vascular responses to mental stress 
and norepinephrine in human forearm. Ihper tens ion  
1994:24:6^4 ft.
2N Ykklarvinen II. Yi ung AA, I amkin l \  Foley JF . Kinetics of 
dueosc  disposal in whole bod\ ami across the forearm in man. 
J Clin Invest 1 W ;7 9 ;1 7 |3  19,
29 Volienweider I \  Tapny  F, Schneitcr l \  Jcquicr 1'. Nicod I\ 
Schcrrer 1'. Differential effects of  hyperinsulinemia and carbo­
hydrate metabolism on sympathetic nerve activity and  muscle 
biood How in humans. J Clin Invest 1993;92:147 >4.
30 DeFronzo RA. Jacot F, Jequier F, M acdcr F. W ah ien  J. I eiber 
JP. The eifect o f  insulin on the disposal o f  in travenous glucose. 
Results from indirect calorimetry and hepatic and  femoral 
venous catheterization, Diabetes |9 9 l ;3 0 :1000 7.
(f ‘ 1996 Blackwell Science Ltd, European Journal o( Clinieal Investigation. 26. 772 77S’
